Article Text

Download PDFPDF
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

Statistics from Altmetric.com

Footnotes

  • Competing interests IM and HW received research funding and honoraria from Abbott, Roche and Schering-Plough, TW and DMO from Abbott, Bristol-Myers Squibb, Roche, UCB and Wyeth/Pfizer.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.